BARCELONA — The immunosuppressant gusperimus showed “remarkable” efficacy in decreasing proteinuria in a small group of patients with longstanding, relapsing lupus nephritis, Dr. Hanns-Martin Lorenz said at the annual European Congress of Rheumatology.
PREVIEW